Danaparoid and disseminated intravascular coagulation Patient Reports February 13, 2012

Danaparoid Side Effects Report #5086058-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5042515-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 18, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5026915-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood urea increased, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5116966-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, DOPAMINE, OMEPRAZOLE, FUROSEMIDE. Patient recovered.


Danaparoid Side Effects Report #5024835-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, DOPAMINE, OMEPRAZOLE, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #5042516-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Male patient, 86 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemorrhage, infection . Danaparoid dosage: unknown. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, CARBENIN, ULINASTATIN, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5124738-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHAGE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5024706-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, CLINDAMYCIN, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SILVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5030495-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHATE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #4975616-4
Danaparoid side effect was reported by a Health Professional from JAPAN on Dec 27, 2005. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemoglobin decreased, infection , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died on 01/21/2005.

Danaparoid Side Effects Report #4991406-0
Danaparoid side effect was reported by a Health Professional from AFGHANISTAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #4995842-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous, haemorrhagic diathesis, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #4975619-X
Danaparoid side effect was reported by a Health Professional from JAPAN on Mar 23, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: asthma , blood bilirubin increased, blood potassium increased, disseminated intravascular coagulation, emphysema, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died on 09/29/2003.

Danaparoid Side Effects Report #5134219-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia. Danaparoid dosage: unknown. During the same period patient was treated with PENICILLIN G POTASSIUM. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5113484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, postoperative wound infection. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, SIVELESTAT, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5027823-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, operative haemorrhage, postoperative wound infection. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, SIVELESTAT, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5030651-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, hepatic function abnormal, malnutrition, postoperative infection, renal impairment, wound haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5030481-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with PENICILLIN G POTASSIUM. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5124726-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.


Danaparoid Side Effects Report #5024837-3
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on June 01, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, sepsis , septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #4941617-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Feb 23, 2006. Male patient, 53 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, disease recurrence, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, GABEXATE MESILATE, ARBEKACIN SULPHATE, OMEPRAZOLE, PREDNISOLONE. Patient recovered.

Danaparoid Side Effects Report #4948452-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 07, 2006. Male patient, 53 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, GABEXATE MESILATE, ARBEKACIN SULPHATE, OMEPRAZOLE, PREDNISOLONE, VANCOMYCIN HYDROCHLORIDE, PAZUFLOXACIN. Patient died.

Danaparoid Side Effects Report #5123364-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, platelet count increased, protein total decreased, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5024840-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, renal impairment, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.


Danaparoid Side Effects Report #5030494-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, renal impairment, sepsis , thermal burn. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5116965-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, CILASTATIN W, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5024833-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, TIENAM, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5116967-2
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 19, 2006. Male patient, 74 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, condition aggravated, disseminated intravascular coagulation, haematuria, hepatic function abnormal, malnutrition, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE, TEICOPLANIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5132974-8
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Oct 10, 2006. Male patient, 67 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cyanosis, disseminated intravascular coagulation, heparin-induced thrombocytopenia, intestinal ischaemia, pain , septic shock, thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, ASPIRIN, FUROSEMIDE. Patient recovered.